1261 Enzyme Replacement Therapy with Velaglucerase Alfa Improves Key Clinical Parameters in a Pediatric Subgroup with Type 1 Gaucher Disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details